Goldman Sachs Group Inc Enovis Corp Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Enovis Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 591,272 shares of ENOV stock, worth $19.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

591,272

Previous 267,617 120.94%

Holding current value

$19.1 Million

Previous $10.2 Million 81.34%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$29.65 - $37.35 $9.6 Million - $12.1 Million	323,655 Added 120.94%	591,272 $18.5 Million
Q1 2025 May 09, 2025	BUY	$35.51 - $47.99 $2.6 Million - $3.51 Million	73,116 Added 37.59%	267,617 $10.2 Million
Q4 2024 Feb 11, 2025	SELL	$38.5 - $49.33 $6.37 Million - $8.17 Million	-165,525 Reduced 45.98%	194,501 $8.54 Million
Q3 2024 Nov 14, 2024	SELL	$40.57 - $48.1 $5.82 Million - $6.9 Million	-143,520 Reduced 28.5%	360,026 $15.5 Million
Q2 2024 Aug 13, 2024	BUY	$44.56 - $62.43 $1.7 Million - $2.39 Million	38,242 Added 8.22%	503,546 $22.8 Million
Q1 2024 May 15, 2024	SELL	$55.44 - $63.8 $3.82 Million - $4.39 Million	-68,875 Reduced 12.89%	465,304 $29.1 Million
Q4 2023 Feb 13, 2024	BUY	$43.67 - $57.07 $1.28 Million - $1.67 Million	29,229 Added 5.79%	534,179 $29.9 Million
Q3 2023 May 14, 2024	SELL	$51.65 - $65.54 $1.51 Million - $1.92 Million	-29,229 Reduced 5.47%	504,950 $26.6 Million
Q3 2023 Nov 14, 2023	SELL	$51.65 - $65.54 $1.83 Million - $2.32 Million	-35,471 Reduced 6.56%	504,950 $26.6 Million
Q2 2023 May 14, 2024	SELL	$52.7 - $64.12 $2.09 Million - $2.54 Million	-39,690 Reduced 6.84%	540,421 $34.7 Million
Q2 2023 Aug 14, 2023	SELL	$52.7 - $64.12 $2.09 Million - $2.54 Million	-39,690 Reduced 6.84%	540,421 $34.7 Million
Q1 2023 May 14, 2024	SELL	$49.5 - $65.92 $13.3 Million - $17.8 Million	-269,505 Reduced 31.72%	580,111 $31 Million
Q1 2023 May 11, 2023	SELL	$49.5 - $65.92 $13.3 Million - $17.8 Million	-269,505 Reduced 31.72%	580,111 $31 Million
Q4 2022 May 14, 2024	SELL	$44.83 - $57.43 $1.47 Million - $1.88 Million	-32,810 Reduced 3.72%	849,616 $45.5 Million
Q4 2022 Feb 13, 2023	SELL	$44.83 - $57.43 $1.47 Million - $1.88 Million	-32,810 Reduced 3.72%	849,616 $45.5 Million
Q3 2022 May 14, 2024	SELL	$46.07 - $60.1 $2.89 Million - $3.76 Million	-62,632 Reduced 6.63%	882,426 $40.7 Million
Q3 2022 Nov 10, 2022	SELL	$46.07 - $60.1 $2.89 Million - $3.76 Million	-62,632 Reduced 6.63%	882,426 $0
Q2 2022 May 14, 2024	BUY	$55.0 - $70.47 $22.6 Million - $29 Million	410,879 Added 76.92%	945,058 $52 Million
Q2 2022 Aug 15, 2022	BUY	$55.0 - $70.47 $52 Million - $66.6 Million	945,058 New	945,058 $52 Million

Others Institutions Holding ENOV

# of Institutions

315

Shares Held

64.3M

Call Options Held

2.02M

Put Options Held

332K

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $1.75B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Enovis Corp Transaction History